Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Vivani Medical Inc. (VANI:NASDAQ), powered by AI.
Vivani Medical Inc. is currently trading at $1.17. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Vivani Medical Inc. on Alpha Lenz.
Vivani Medical Inc.'s P/E ratio is -2.7.
“Vivani Medical Inc. trades at a P/E of -2.7 (undervalued) with modest ROE of -159.6%.”
Ask for details →Vivani Medical Inc. is a specialized biotechnology and medical device company focused on developing innovative solutions in the healthcare sector. Their primary focus is on addressing chronic diseases and improving patient outcomes through the integration of advanced technologies in bioelectronics. Vivani Medical is particularly notable for its work in creating cutting-edge, implantable medical devices designed to enhance the quality of life for individuals living with sensory deficits and chronic pain. This company operates at the intersection of bioengineering and healthcare, pioneering efforts in providing long-term therapeutic solutions. With a commitment to improving health outcomes, Vivani Medical's developments have potential implications across various medical fields, including neuroscience and chronic disease management, thus playing a significant role in the evolving landscape of medical technology. Their innovative approach underscores the growing importance of bioelectronic medicine as an emerging field that holds promise for addressing some of the most challenging health issues.
“Vivani Medical Inc. trades at a P/E of -2.7 (undervalued) with modest ROE of -159.6%.”
Ask for details →Vivani Medical Inc. (ticker: VANI) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 37 employees. Market cap is $73M.
The current price is $1.17 with a P/E ratio of -2.74x and P/B of 4.64x.
ROE is -159.62%.